F
Francesco Orofino
Researcher at University of Siena
Publications - 8
Citations - 83
Francesco Orofino is an academic researcher from University of Siena. The author has contributed to research in topics: Chemistry & ADME. The author has an hindex of 4, co-authored 6 publications receiving 42 citations.
Papers
More filters
Journal ArticleDOI
Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents
Claudio Zamperini,Giorgio Maccari,Davide Deodato,Carolina Pasero,Ilaria D'Agostino,Francesco Orofino,F. De Luca,Elena Dreassi,Jean Denis Docquier,Maurizio Botta,Maurizio Botta +10 more
TL;DR: A batch of a promising candidate for optimization studies turned out to be a mixture containing two unknown species with a better biological activity than the pure compound, and this serendipitous discovery led to investigate the chemical nature of the unknown components of the mixture.
Journal ArticleDOI
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains
Francesco Orofino,Giuseppina I. Truglio,Diego Fiorucci,Ilaria D'Agostino,Matteo Borgini,Federica Poggialini,Claudio Zamperini,Elena Dreassi,Laura Maccari,Riccardo Torelli,Cecilia Martini,Micaela Bernabei,Jacques F. Meis,Nitesh Kumar Khandelwal,Rajendra Prasad,Maurizio Sanguinetti,Francesca Bugli,Maurizio Botta +17 more
TL;DR: The research highlights the low in vivo toxicity profile of BM1, its affinity for the renal system in rats and its good absorption, distribution, metabolism, and excretion (ADME) features, which make BM1 and its derivatives a novel promising antifungal class.
Journal ArticleDOI
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors.
Diego Fiorucci,Eva Milletti,Francesco Orofino,Antonella Brizzi,Claudia Mugnaini,Federico Corelli +5 more
TL;DR: A computational virtual screening procedure for the repurposing of commercial drugs available in the DrugBank database as inhibitors of the SARS-CoV-2 main protease was used, highlighting five interesting drugs that showed a comparable or higher docking score compared to the crystallographic compound and maintained the protein binding during the MD runs.
Journal ArticleDOI
Design and synthesis of a novel inhibitor of T. Viride chitinase through an in silico target fishing protocol
Giorgio Maccari,Davide Deodato,Diego Fiorucci,Francesco Orofino,Giuseppina I. Truglio,Carolina Pasero,Riccardo Martini,Filomena De Luca,Jean Denis Docquier,Maurizio Botta,Maurizio Botta +10 more
TL;DR: The data suggest that chitinase represent at least one of the main target of macrocyclic amidinoureas, and a novel macro cyclic derivative has been produced, specifically designed to increase the inhibition of the chitInase.
Journal ArticleDOI
AuNP Pyrazolo[3,4-d]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.
Alessio Molinari,Giulia Iovenitti,Arianna Mancini,Arianna Mancini,Giovanni Luca Gravina,Monia Chebbi,Monia Chebbi,Maura Caruana,Giulia Vignaroli,Francesco Orofino,Enrico Rango,Adriano Angelucci,Elena Dreassi,Silvia Schenone,Maurizio Botta,Maurizio Botta +15 more
TL;DR: Gold-nanoparticle (AuNP)-conjugated drugs represent a promising and innovative antitumor therapeutic approach and it was demonstrated that AuNPs had a basal radiosensitization ability and that auNPs-SI306, when used in combination with RT, were more effective in inhibiting tumor cell growth with respect to AuNps and free SI306.